Short Summary
MediaTek and Daedalus Prime filed a joint motion to terminate their IPR, accompanied by a confidential settlement agreement. The PTAB granted the termination and ordered the settlement to be kept confidential.
Detailed Summary
In IPR2025-00100 concerning U.S. Patent 9,887,838 B2, MediaTek Inc. and Daedalus Prime LLC jointly moved to terminate the proceeding after the trial had been instituted. They also submitted a settlement agreement, which they requested be treated as business confidential information under 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c). The Patent Trial and Appeal Board agreed, granting the termination for both parties and ordering the settlement to be kept separate from the patent file and disclosed only upon written request and good cause. No claim constructions or unpatentability findings were made.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in MediaTek Inc. vs DAEDALUS PRIME LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Luxottica of America Inc.vsE-Vision Smart Optics, Inc.
The PTAB granted institution for IPR2025-01512, allowing Luxottica to challenge E-Vision's patent 11971612 on the merits.
Amazon.com, Inc. et al.vsLowenstein & Weatherwax LLP
Amazon and AWS filed an unopposed motion to withdraw their IPR challenge to DivX's video‑transcoding patent (U.S. 10,715,806). The Board was asked to terminate the proceeding, citing good cause and efficiency.
Apple Inc.vsImberaTek, LLC
Apple and ImberaTek settled their disputes, leading the PTAB to terminate nine inter partes review proceedings before any institution decision. The settlement agreement was ordered to be kept confidential.
VIVITRO LABS INC.vsBIOMEDICAL DEVICE CONSULTANTS & LABORATORIES OF COLORADO, LLC
VIVITRO LABS INC. successfully achieved institution at the PTAB for its IPR against Patent No. 9237935, challenging claims related to prosthetic heart valve testing systems. The Board found a reasonable likelihood of success over Dynatek regarding certain limitations, despite preliminary rejections on other grounds.
BOE Technology Group Co., Ltd.vsSamsung Display Co., Ltd.
BOE Technology and Samsung Display have settled all disputes over U.S. Patent 10,832,616 and jointly moved to terminate the inter partes review. The Board is asked to dismiss the proceeding under 35 U.S.C. §317.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.